Next, we investigated the in vivo activity of FM using an EPOR-JAK2V617F-driven MPN mouse model, as the EPOR (erythropoietin receptor) gene activates JAK2 tyrosine kinase [42, 43]. The gene discussed is JAK2; the disease is myeloproliferative disorder.